Skip to main content
. 2021 Jun 2;28(13):9073–9083. doi: 10.1245/s10434-021-10190-z

Fig. 3.

Fig. 3.

Sites of first recurrent disease after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) in patients with synchronous or metachronous colorectal peritoneal metastases.